Lucid Diagnostics
LUCD
34 hedge funds and large institutions have $1.64M invested in Lucid Diagnostics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
13% more funds holding
Funds holding: 30 → 34 (+4)
0.49% less ownership
Funds ownership: 4.29% → 3.8% (-0.49%)
3% less capital invested
Capital invested by funds: $1.69M → $1.64M (-$52.2K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lido Advisors
Los Angeles,
California
|
+$57.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$41.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$23.5K |
| 4 |
AA
Axiom Advisory
San Diego,
California
|
+$12.7K |
| 5 |
OIA
OneDigital Investment Advisors
Overland Park,
Kansas
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$98.8K |
| 2 |
HF
HRT Financial
New York
|
-$51K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.7K |
| 4 |
BlackRock
New York
|
-$20.6K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$19.8K |
LUCD Hedge Fund Activity: Q2 2024 in Review
34 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q2 2024, worth a combined $1.64M — down 3.1% from $1.69M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LUCD positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 9 trimmed.
The largest buyer was Lido Advisors, opening a new position worth an estimated $57.7K. The largest seller was Jane Street, exiting entirely with an estimated $98.8K sold.
- 34 institutional investors held Lucid Diagnostics (LUCD) as of Q2 2024, up from 30 in Q1 2024.
- Funds reported $1.64M of Lucid Diagnostics stock for Q2 2024, down 3.1% quarter-over-quarter.
- 8 funds opened new Lucid Diagnostics positions in Q2 2024 and 4 closed out, a net change of +4 holders.
- The largest Lucid Diagnostics buyer in Q2 2024 was Lido Advisors, an estimated $57.7K added.
- The largest Lucid Diagnostics seller in Q2 2024 was Jane Street, an estimated $98.8K sold.
Based on aggregated 13F filings for Q2 2024.